MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 22, 2007; DOI: 10.1124/mol.107.039446


0026-895X/07/7205-1210-1219$20.00
Mol Pharmacol 72:1210-1219, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.039446v1
72/5/1210    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, E.-J.
Right arrow Articles by Hamm, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, E.-J.
Right arrow Articles by Hamm, H. E.

Gbeta{gamma} Interferes with Ca2+-Dependent Binding of Synaptotagmin to the Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor (SNARE) ComplexFormula

Eun-Ja Yoon, Tatyana Gerachshenko, Bryan D. Spiegelberg, Simon Alford, and Heidi E. Hamm

Department of Pharmacology, Vanderbilt University Medical School, Nashville, Tennessee (E.J.Y., B.D.S., H.E.H.); and Department of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois (T.G., S.A.).

Presynaptic inhibitory G protein-coupled receptors (GPCRs) can decrease neurotransmission by inducing interaction of Gbeta{gamma} with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. We have shown that this action of Gbeta{gamma} requires the carboxyl terminus of the 25-kDa synaptosome-associated protein (SNAP25) and is downstream of the well known inhibition of Ca2+ entry through voltage-gated calcium channels. We propose a mechanism in which Gbeta{gamma} and synaptotagmin compete for binding to the SNARE complex. Here, we characterized the Gbeta{gamma} interaction sites on syntaxin1A and SNAP25 and demonstrated an overlap of the Gbeta{gamma}- and synaptotagmin I -binding regions on each member of the SNARE complex. Synaptotagmin competes in a Ca2+-sensitive manner with binding of Gbeta{gamma} to SNAP25, syntaxin1A, and the assembled SNARE complex. We predict, based on these findings, that at high intracellular Ca2+ concentrations, Ca2+-synaptotagmin I can displace Gbeta{gamma} binding and the Gbeta{gamma}-dependent inhibition of exocytosis can be blocked. We tested this hypothesis in giant synapses of the lamprey spinal cord, where 5-HT works via Gbeta{gamma} to inhibit neurotransmission (Blackmer et al., 2001). We showed that increased presynaptic Ca2+ suppresses the 5-HT- and Gbeta{gamma}-dependent inhibition of exocytosis. We suggest that this effect may be due to Ca2+-dependent competition between Gbeta{gamma} and synaptotagmin I for SNARE binding. This type of dynamic regulation may represent a novel mechanism for modifying transmitter release in a graded manner based on the history of action potentials that increase intracellular Ca2+ concentrations and of inhibitory signals through Gi-coupled GPCRs.


Received June 27, 2007; accepted August 22, 2007

Address correspondence to: Heidi E. Hamm, Department of Pharmacology, Vanderbilt University Medical School, 23rd Ave. South at Pierce, Nashville, TN 37232. E-mail: heidi.hamm{at}vanderbilt.edu




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. M. Silinsky
Selective disruption of the mammalian secretory apparatus enhances or eliminates calcium current modulation in nerve endings
PNAS, April 29, 2008; 105(17): 6427 - 6432.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics